RAND and UCSF Researchers: Post–Schedule III Implications — Warn Research Constraints Would Persist If DEA Keeps Cannabis on Schedule I
RAND and UCSF researchers warn that even after a DEA reclassification to Schedule III, some research restrictions could remain. They argue that additional regulatory reforms will be required to achieve full research liberalization and remove lingering barriers to cannabis studies.
For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.
Source
theconversation.com
This content is a summary and editorial by CannabisInsight based on the above source. Copyright of the original article belongs to the respective publisher.
Original Link
https://theconversation.com/reclassification-of-marijuana-opens-doors-for-much-needed-medical-research-into-the-benefits-and-risks-of-the-drug-281403